Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients

Abstract Obesity could lead to metabolic dysfunction-associated fatty liver disease (MAFLD), which severity could be linked to muscle and gut microbiota disturbances. Our prospective study enrolled 52 obese patients whose MAFLD severity was estimated by transient elastography. Patients with severe s...

Full description

Bibliographic Details
Main Authors: Nicolas Lanthier, Julie Rodriguez, Maxime Nachit, Sophie Hiel, Pierre Trefois, Audrey M. Neyrinck, Patrice D. Cani, Laure B. Bindels, Jean-Paul Thissen, Nathalie M. Delzenne
Format: Article
Language:English
Published: Nature Portfolio 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-79718-9
_version_ 1818840135608827904
author Nicolas Lanthier
Julie Rodriguez
Maxime Nachit
Sophie Hiel
Pierre Trefois
Audrey M. Neyrinck
Patrice D. Cani
Laure B. Bindels
Jean-Paul Thissen
Nathalie M. Delzenne
author_facet Nicolas Lanthier
Julie Rodriguez
Maxime Nachit
Sophie Hiel
Pierre Trefois
Audrey M. Neyrinck
Patrice D. Cani
Laure B. Bindels
Jean-Paul Thissen
Nathalie M. Delzenne
author_sort Nicolas Lanthier
collection DOAJ
description Abstract Obesity could lead to metabolic dysfunction-associated fatty liver disease (MAFLD), which severity could be linked to muscle and gut microbiota disturbances. Our prospective study enrolled 52 obese patients whose MAFLD severity was estimated by transient elastography. Patients with severe steatosis (n = 36) had higher ALAT values, fasting blood glucose levels as well as higher visceral adipose tissue area and skeletal muscle index evaluated by computed tomography. Patients with fibrosis (n = 13) had higher ASAT values, increased whole muscle area and lower skeletal muscle density index. In a multivariate logistic regression analysis, myosteatosis was the strongest factor associated with fibrosis. Illumina sequencing of 16S rRNA gene amplicon was performed on fecal samples. The relative abundance of fecal Clostridium sensu stricto was significantly decreased with the presence of liver fibrosis and was negatively associated with liver stiffness measurement and myosteatosis. In addition, 19 amplicon sequence variants were regulated according to the severity of the disease. Linear discriminant analysis effect size (LEfSe) also highlighted discriminant microbes in patients with fibrosis, such as an enrichment of Enterobacteriaceae and Escherichia/Shigella compared to patients with severe steatosis without fibrosis. All those data suggest a gut-liver-muscle axis in the pathogenesis of MAFLD complications.
first_indexed 2024-12-19T04:05:22Z
format Article
id doaj.art-023ec02cb2dd45cc98da54f66da34aec
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T04:05:22Z
publishDate 2021-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-023ec02cb2dd45cc98da54f66da34aec2022-12-21T20:36:32ZengNature PortfolioScientific Reports2045-23222021-01-0111111410.1038/s41598-020-79718-9Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patientsNicolas Lanthier0Julie Rodriguez1Maxime Nachit2Sophie Hiel3Pierre Trefois4Audrey M. Neyrinck5Patrice D. Cani6Laure B. Bindels7Jean-Paul Thissen8Nathalie M. Delzenne9Laboratory of Hepatology and Gastroenterology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Université catholique de LouvainMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de LouvainLaboratory of Hepatology and Gastroenterology, Institut de Recherche Expérimentale et Clinique, UCLouvain, Université catholique de LouvainMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de LouvainMedical and Imaging Department, Cliniques universitaires Saint-Luc, UCLouvainMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de LouvainMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de LouvainMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de LouvainPole of Endocrinology, Diabetes and Nutrition, Institut de Recherche Expérimentale et Clinique, UCLouvain, Université catholique de LouvainMetabolism and Nutrition Research Group, Louvain Drug Research Institute, UCLouvain, Université catholique de LouvainAbstract Obesity could lead to metabolic dysfunction-associated fatty liver disease (MAFLD), which severity could be linked to muscle and gut microbiota disturbances. Our prospective study enrolled 52 obese patients whose MAFLD severity was estimated by transient elastography. Patients with severe steatosis (n = 36) had higher ALAT values, fasting blood glucose levels as well as higher visceral adipose tissue area and skeletal muscle index evaluated by computed tomography. Patients with fibrosis (n = 13) had higher ASAT values, increased whole muscle area and lower skeletal muscle density index. In a multivariate logistic regression analysis, myosteatosis was the strongest factor associated with fibrosis. Illumina sequencing of 16S rRNA gene amplicon was performed on fecal samples. The relative abundance of fecal Clostridium sensu stricto was significantly decreased with the presence of liver fibrosis and was negatively associated with liver stiffness measurement and myosteatosis. In addition, 19 amplicon sequence variants were regulated according to the severity of the disease. Linear discriminant analysis effect size (LEfSe) also highlighted discriminant microbes in patients with fibrosis, such as an enrichment of Enterobacteriaceae and Escherichia/Shigella compared to patients with severe steatosis without fibrosis. All those data suggest a gut-liver-muscle axis in the pathogenesis of MAFLD complications.https://doi.org/10.1038/s41598-020-79718-9
spellingShingle Nicolas Lanthier
Julie Rodriguez
Maxime Nachit
Sophie Hiel
Pierre Trefois
Audrey M. Neyrinck
Patrice D. Cani
Laure B. Bindels
Jean-Paul Thissen
Nathalie M. Delzenne
Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
Scientific Reports
title Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
title_full Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
title_fullStr Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
title_full_unstemmed Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
title_short Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
title_sort microbiota analysis and transient elastography reveal new extra hepatic components of liver steatosis and fibrosis in obese patients
url https://doi.org/10.1038/s41598-020-79718-9
work_keys_str_mv AT nicolaslanthier microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT julierodriguez microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT maximenachit microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT sophiehiel microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT pierretrefois microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT audreymneyrinck microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT patricedcani microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT laurebbindels microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT jeanpaulthissen microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients
AT nathaliemdelzenne microbiotaanalysisandtransientelastographyrevealnewextrahepaticcomponentsofliversteatosisandfibrosisinobesepatients